Clinical Trials Logo

Cognitively Normal Older Adults clinical trials

View clinical trials related to Cognitively Normal Older Adults.

Filter by:
  • None
  • Page 1

NCT ID: NCT06364189 Recruiting - Clinical trials for Cognitively Normal Older Adults

Inspiring Seniors Toward Exercise Promotion

iSTEP
Start date: April 15, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test the benefits of beat-accented music stimulation (BMS) for behavioral changes of physical activity (PA) in older adults. Specific Aims are to determine (1) whether BMS beneficially influences PA behaviors and psychological responses to PA in older adults for 6 months, and (2) whether exercising with BMS differently influences physical and cognitive functioning as well as quality of life in older adults. To test the effects of BMS on PA, participants will be randomly assigned to an exercise intervention that either includes BMS or does not include BMS. Participants will attend a supervised group strength training (ST) (30 min/day) and aerobic exercise (AE) (30-50 min/day) session for 3 days/week for the first 2 months, 1 day/week for the next 2 months (while encouraging participants to independently perform both AE and ST on other days), and independently for the final 2 months (always with a goal of performing >150min/week AE and 3 days/week of ST for 30 min/day.

NCT ID: NCT05980286 Completed - Aging Clinical Trials

Impact of Musical Improvisation Training on Cognitive Function in Older Adults

Start date: October 15, 2022
Phase: N/A
Study type: Interventional

This project will develop and test the effects and mechanisms of a music improvisation training intervention on self-regulation of older adults with and without MCI. The investigator's overall hypothesis is that improvisation training will lead to improvements in self-regulation, compared to controls, and that improvisation training will be associated with specific changes in prefrontal brain networks and ultimately cognitive engagement.

NCT ID: NCT05331144 Recruiting - Hypertension Clinical Trials

Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)

IPAT
Start date: October 25, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if intensive lowering of systolic blood pressure (SBP), using FDA approved medications (antihypertensive), reduces Alzheimer's Disease pathology (i.e., excessive brain amyloid and tau protein deposition) in older adults at high risk for memory decline or dementia.

NCT ID: NCT02913664 Completed - Hypertension Clinical Trials

Risk Reduction for Alzheimer's Disease

rrAD
Start date: February 2, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

Physical inactivity, high blood pressure and dyslipidemia are risk factors for Alzheimer's disease (AD) and vascular dementia. Importantly, these risk factors are modifiable with lifestyle changes, pharmacological treatment, or both. The rrAD study will determine effects of aerobic exercise training and intensive vascular risk reduction on cognitive performance in older adults who have high risk for AD.